Effects of parenteral lipid infusion on DNA damage in very low birth weight infants

Toshiaki Shimizu1, Yayoi Satoh, Hiromichi Syoji

  • 1Department of Pediatrics, Juntendo University School of Medicine 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. tsimizut@aol.com

Free Radical Research
|January 9, 2003
PubMed

Insights

Parenteral lipid infusion did not increase DNA damage in very low birth weight (VLBW) infants. However, DNA damage markers were higher in the first week of life compared to 14 days old, regardless of lipid infusion.

Area of Science:

  • Neonatalogy
  • Oxidative Stress Research
  • Biomarker Analysis

Background:

  • Very low birth weight (VLBW) infants possess underdeveloped antioxidant systems, increasing susceptibility to radical damage.
  • Parenteral nutrition lipid emulsions have been linked to elevated lipid peroxide products in prior research.
  • The direct impact of parenteral lipid infusion on DNA damage in VLBW infants requires further investigation.

Purpose of the Study:

  • To assess the direct effects of parenteral lipid infusion on DNA damage in VLBW infants.
  • To quantify urinary 8-hydroxydeoxyguanosine (8-OHdG) levels as a biomarker of oxidative DNA damage.

Main Methods:

  • Urinary 8-hydroxydeoxyguanosine (8-OHdG) levels were measured in VLBW infants.
  • Measurements were taken before, during, and after parenteral lipid infusion.
  • Infants were divided into lipid-infused and lipid-free groups for comparison.

Main Results:

  • Urinary 8-OHdG excretion decreased significantly by 14 days old in both groups (p < 0.01).
  • No significant differences in 8-OHdG levels were observed between lipid-infused and lipid-free groups at 2, 7, or 14 days old.
  • DNA damage was elevated during the first week of life compared to 14 days old, irrespective of lipid infusion.

Conclusions:

  • Parenteral lipid infusion does not appear to induce oxidative DNA damage in VLBW infants.
  • VLBW infants experience enhanced DNA damage during their first week of life, which diminishes by 14 days old.
  • Further research may explore the underlying causes of early-life DNA damage in VLBW infants.

Related Concept Videos